The Problems of Anticholinergic Adverse Effects in Older Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-07

AUTHORS

Madeline Feinberg

ABSTRACT

The old saying ‘red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter’ is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems. More... »

PAGES

335-348

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004

DOI

http://dx.doi.org/10.2165/00002512-199303040-00004

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015621468

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8369593


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholinergic Fibers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parasympatholytics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feinberg", 
        "givenName": "Madeline", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00265918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030251315", 
          "https://doi.org/10.1007/bf00265918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-73666-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042607275", 
          "https://doi.org/10.1007/978-3-642-73666-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-199101050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005875965", 
          "https://doi.org/10.2165/00002512-199101050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-198937010-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024913304", 
          "https://doi.org/10.2165/00003495-198937010-00008"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-07", 
    "datePublishedReg": "1993-07-01", 
    "description": "The old saying \u2018red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter\u2019 is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems.", 
    "genre": "article", 
    "id": "sg:pub.10.2165/00002512-199303040-00004", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "older patients", 
      "anticholinergic effects", 
      "mild confusion", 
      "elderly patients", 
      "heart rate", 
      "central anticholinergic effects", 
      "anticholinergic adverse effects", 
      "narrow-angle glaucoma", 
      "pharmacokinetic drug interactions", 
      "serious respiratory infections", 
      "muscarinic cholinergic system", 
      "drug-induced problems", 
      "level of care", 
      "quality of life", 
      "loss of independence", 
      "disease-related conditions", 
      "urinary hesitancy", 
      "anticholinergic challenge", 
      "frank delirium", 
      "dry mouth", 
      "fecal impaction", 
      "urinary retention", 
      "younger patients", 
      "cardiac effects", 
      "drug regimen", 
      "gastrointestinal motility", 
      "mucosal damage", 
      "respiratory infections", 
      "autonomic effects", 
      "anticholinergic action", 
      "dental caries", 
      "heat intolerance", 
      "pathophysiological changes", 
      "angle glaucoma", 
      "caregiver burden", 
      "anticholinergic toxicity", 
      "cholinergic system", 
      "common finding", 
      "patient education", 
      "drug interactions", 
      "drug toxicity", 
      "patients", 
      "multiple drugs", 
      "thermoregulatory impairment", 
      "older age", 
      "good health", 
      "somatic complaints", 
      "adverse effects", 
      "drugs", 
      "regular review", 
      "sedation", 
      "complaints", 
      "risk", 
      "mild effect", 
      "toxicity", 
      "careful attention", 
      "aging process", 
      "constipation", 
      "angina", 
      "anticholinergics", 
      "delirium", 
      "mydriasis", 
      "regimen", 
      "glaucoma", 
      "caries", 
      "symptoms", 
      "malnutrition", 
      "infection", 
      "intolerance", 
      "secretion", 
      "impairment", 
      "risk of accidents", 
      "care", 
      "impaction", 
      "inability", 
      "age", 
      "effect", 
      "hesitancy", 
      "saliva", 
      "burden", 
      "bone", 
      "antimicrobial activity", 
      "hyperthermia", 
      "signs", 
      "health", 
      "life", 
      "rate", 
      "motility", 
      "loss", 
      "review", 
      "confusion", 
      "findings", 
      "damage", 
      "fall", 
      "mouth", 
      "ability", 
      "levels", 
      "activity", 
      "action", 
      "vision", 
      "increase", 
      "accidents", 
      "changes", 
      "presence", 
      "use", 
      "familiarity", 
      "retention", 
      "function", 
      "quality", 
      "consequences", 
      "bats", 
      "education", 
      "challenges", 
      "conditions", 
      "attention", 
      "independence", 
      "hares", 
      "problem", 
      "interaction", 
      "cost", 
      "system", 
      "natural consequence", 
      "process", 
      "dependency", 
      "beet", 
      "Hatter", 
      "misfit"
    ], 
    "name": "The Problems of Anticholinergic Adverse Effects in Older Patients", 
    "pagination": "335-348", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015621468"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00002512-199303040-00004"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8369593"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00002512-199303040-00004", 
      "https://app.dimensions.ai/details/publication/pub.1015621468"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_253.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.2165/00002512-199303040-00004"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      164 URIs      152 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00002512-199303040-00004 schema:about N5601950e314042339132eed68df3baf1
2 N73e4cd3c76044943af7743014722aaef
3 N7f66ec0c7f9b419b86b3d83fae9bb02b
4 N8e609ed98e084738a55014867c244bbb
5 Nbc8abd2b42e1426d8adc42ff6c9a4ae2
6 Neea710f3a8544789996b74617bb8d874
7 Nf5e5b3cb9f814f3da82a806a6a1df9bb
8 anzsrc-for:11
9 anzsrc-for:1115
10 schema:author Nf150e6f5636b4ebb85b5dc12d71777d1
11 schema:citation sg:pub.10.1007/978-3-642-73666-7
12 sg:pub.10.1007/bf00265918
13 sg:pub.10.2165/00002512-199101050-00006
14 sg:pub.10.2165/00003495-198937010-00008
15 schema:datePublished 1993-07
16 schema:datePublishedReg 1993-07-01
17 schema:description The old saying ‘red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter’ is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf Nc4d43cacd8e14c66b1a6ddc4c4e98a49
21 Nf2d8acfabeab4e29b7594b64b41783a1
22 sg:journal.1100990
23 schema:keywords Hatter
24 ability
25 accidents
26 action
27 activity
28 adverse effects
29 age
30 aging process
31 angina
32 angle glaucoma
33 anticholinergic action
34 anticholinergic adverse effects
35 anticholinergic challenge
36 anticholinergic effects
37 anticholinergic toxicity
38 anticholinergics
39 antimicrobial activity
40 attention
41 autonomic effects
42 bats
43 beet
44 bone
45 burden
46 cardiac effects
47 care
48 careful attention
49 caregiver burden
50 caries
51 central anticholinergic effects
52 challenges
53 changes
54 cholinergic system
55 common finding
56 complaints
57 conditions
58 confusion
59 consequences
60 constipation
61 cost
62 damage
63 delirium
64 dental caries
65 dependency
66 disease-related conditions
67 drug interactions
68 drug regimen
69 drug toxicity
70 drug-induced problems
71 drugs
72 dry mouth
73 education
74 effect
75 elderly patients
76 fall
77 familiarity
78 fecal impaction
79 findings
80 frank delirium
81 function
82 gastrointestinal motility
83 glaucoma
84 good health
85 hares
86 health
87 heart rate
88 heat intolerance
89 hesitancy
90 hyperthermia
91 impaction
92 impairment
93 inability
94 increase
95 independence
96 infection
97 interaction
98 intolerance
99 level of care
100 levels
101 life
102 loss
103 loss of independence
104 malnutrition
105 mild confusion
106 mild effect
107 misfit
108 motility
109 mouth
110 mucosal damage
111 multiple drugs
112 muscarinic cholinergic system
113 mydriasis
114 narrow-angle glaucoma
115 natural consequence
116 older age
117 older patients
118 pathophysiological changes
119 patient education
120 patients
121 pharmacokinetic drug interactions
122 presence
123 problem
124 process
125 quality
126 quality of life
127 rate
128 regimen
129 regular review
130 respiratory infections
131 retention
132 review
133 risk
134 risk of accidents
135 saliva
136 secretion
137 sedation
138 serious respiratory infections
139 signs
140 somatic complaints
141 symptoms
142 system
143 thermoregulatory impairment
144 toxicity
145 urinary hesitancy
146 urinary retention
147 use
148 vision
149 younger patients
150 schema:name The Problems of Anticholinergic Adverse Effects in Older Patients
151 schema:pagination 335-348
152 schema:productId N369eea847f694d1cbf0d3d74e5914676
153 Na4b9925c3b7047b2be60a905abeba233
154 Nc08d0c6756a049bdb4b2d60ee4d0f94b
155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015621468
156 https://doi.org/10.2165/00002512-199303040-00004
157 schema:sdDatePublished 2022-09-02T15:47
158 schema:sdLicense https://scigraph.springernature.com/explorer/license/
159 schema:sdPublisher Neab6370f9ce241489e9c15b071b0086d
160 schema:url https://doi.org/10.2165/00002512-199303040-00004
161 sgo:license sg:explorer/license/
162 sgo:sdDataset articles
163 rdf:type schema:ScholarlyArticle
164 N369eea847f694d1cbf0d3d74e5914676 schema:name doi
165 schema:value 10.2165/00002512-199303040-00004
166 rdf:type schema:PropertyValue
167 N5601950e314042339132eed68df3baf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Humans
169 rdf:type schema:DefinedTerm
170 N73e4cd3c76044943af7743014722aaef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Drug Therapy
172 rdf:type schema:DefinedTerm
173 N7f66ec0c7f9b419b86b3d83fae9bb02b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Parasympatholytics
175 rdf:type schema:DefinedTerm
176 N8e609ed98e084738a55014867c244bbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Risk Factors
178 rdf:type schema:DefinedTerm
179 Na4b9925c3b7047b2be60a905abeba233 schema:name dimensions_id
180 schema:value pub.1015621468
181 rdf:type schema:PropertyValue
182 Naad0ece02f944fefb6c7af46179b2b6b schema:affiliation grid-institutes:grid.411024.2
183 schema:familyName Feinberg
184 schema:givenName Madeline
185 rdf:type schema:Person
186 Nbc8abd2b42e1426d8adc42ff6c9a4ae2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Aging
188 rdf:type schema:DefinedTerm
189 Nc08d0c6756a049bdb4b2d60ee4d0f94b schema:name pubmed_id
190 schema:value 8369593
191 rdf:type schema:PropertyValue
192 Nc4d43cacd8e14c66b1a6ddc4c4e98a49 schema:volumeNumber 3
193 rdf:type schema:PublicationVolume
194 Neab6370f9ce241489e9c15b071b0086d schema:name Springer Nature - SN SciGraph project
195 rdf:type schema:Organization
196 Neea710f3a8544789996b74617bb8d874 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Cholinergic Fibers
198 rdf:type schema:DefinedTerm
199 Nf150e6f5636b4ebb85b5dc12d71777d1 rdf:first Naad0ece02f944fefb6c7af46179b2b6b
200 rdf:rest rdf:nil
201 Nf2d8acfabeab4e29b7594b64b41783a1 schema:issueNumber 4
202 rdf:type schema:PublicationIssue
203 Nf5e5b3cb9f814f3da82a806a6a1df9bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Aged
205 rdf:type schema:DefinedTerm
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
210 schema:name Pharmacology and Pharmaceutical Sciences
211 rdf:type schema:DefinedTerm
212 sg:journal.1100990 schema:issn 1170-229X
213 1179-1969
214 schema:name Drugs & Aging
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:pub.10.1007/978-3-642-73666-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042607275
218 https://doi.org/10.1007/978-3-642-73666-7
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/bf00265918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030251315
221 https://doi.org/10.1007/bf00265918
222 rdf:type schema:CreativeWork
223 sg:pub.10.2165/00002512-199101050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005875965
224 https://doi.org/10.2165/00002512-199101050-00006
225 rdf:type schema:CreativeWork
226 sg:pub.10.2165/00003495-198937010-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024913304
227 https://doi.org/10.2165/00003495-198937010-00008
228 rdf:type schema:CreativeWork
229 grid-institutes:grid.411024.2 schema:alternateName Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA
230 schema:name Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...